CLB - Core Laboratories NV

CLB - Core Laboratories NV

https://www.corelab.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

Core Laboratories: Not a Buy Yet, But Still Worth Holding On

Zacks Commentary • 3 weeks ago • score: 0.33

CLB expands globally with new tech labs and energy transition projects while reducing debt but faces tariff pressures, U.S. market softness and demand volatility risks.

Core Laboratories ( CLB ) Down 21.7% Since Last Earnings Report: Can It Rebound?

Zacks Commentary • 3 weeks, 3 days ago • score: 0.18

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Core Laboratories Q2 Earnings Beat Estimates, Expenses Increase Y/Y

Zacks Commentary • 1 month, 3 weeks ago • score: 0.13

CLB's second-quarter earnings beat estimates. However, it declined year over year due to the underperformance of the Reservoir Description segment.

Core Laboratories ( CLB ) Beats Q2 Earnings and Revenue Estimates

Zacks Commentary • 1 month, 3 weeks ago • score: 0.11

Core Laboratories (CLB) delivered earnings and revenue surprises of +5.56% and +1.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories to Post Q2 Earnings: Key Metrics to Watch

Zacks Commentary • 1 month, 4 weeks ago • score: 0.16

CLB's second-quarter revenues are likely to have declined from the year-ago period's level due to weak segment revenues.

Do Options Traders Know Something About Core Laboratories Stock We Don't?

Zacks Commentary • 2 months, 1 week ago • score: 0.05

Investors need to pay close attention to CLB stock based on the movements in the options market lately.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

None

52W High

$21.78

52W Low

$9.72

MA Status:

50D: Above 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.46

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

20.35

Forward P/E (<15 better)

19.76

EV/EBITDA (<8 favorable)

10.80

EV/Revenue (<3 favorable)

1.43

P/S (TTM) (<3 favorable)

1.14

P/B (<3 favorable)

2.27

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

1.01%

Institutions (25–75% balanced)

114.66%

Shares Outstanding

46,893,800

Float

46,383,600

Dividend Yield (2–6% sweet spot)

0.00%

Ex‑Dividend Date

2025-08-04

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

517,378,000

Gross Profit (TTM)

101,204,000

EPS (TTM)

0.62

Profit Margin (>10% good)

0.06%

Operating Margin (TTM) (higher better)

0.10%

ROE (TTM) (>15% strong)

0.12%

EPS YoY (Quarterly) (>10% good)

0.16

Revenue YoY (Quarterly) (>8% good)

0.00

Momentum

Bearish momentum

Value

0.5057

Previous

0.5219

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025